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The association of breast density (% of breast volume involved by fibro-glandular densities) with the risk of interval cancer (IC) was
investigated by reviewing a consecutive series of 346 cancers detected at screening (SDC) during 1996–1999 and of 90 ICs,
reported as negative in the same period and diagnosed in the following 2 years, and comparing them to a random sample of 360
healthy controls. The probability of IC was significantly associated with breast density, whatever grouping (0/1–25/26–74/474%; 0–
25/26–60/61–74/474%; 0–25/26–74/474%) was considered (w
2¼30.67–34.08, Po0.o0.01): 27.8% of all ICs were classified in
the 474% density class, as compared to 7% of SDC and 5% of healthy controls. No significant association to IC was observed for
Wolfe pattern (P2/Dy vs N1/P1: w
2¼0.30, P¼0.960), number of used mammographic views (single oblique vs obliqueþcranio-
craniocaudal: w
2¼0.02, P¼0.90) or screening round (first vs repeat: w
2¼1.41, P¼0.23). Multivariate analysis confirmed the
independent association of breast density to IC, the highest risk being observed for 474% density class (OR vs 0% class¼13.4, 95%
CI 2.7–65.6, OR vs all other density classes¼5.1, 95% CI 2.6–10.0). Age showed an independent association too, older women
having a lower risk of IC (OR¼0.52 95% CI 0.3–09). Breast density (474%) resulted as being a major determinant of IC. Special
screening protocols (shorter rescreening interval, routine use of ultrasonography) might be suggested for these subjects in order to
improve screening sensitivity and efficacy.
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Mammographic screening is effective in reducing breast cancer
mortality (Wald et al, 1993), although its sensitivity is not high.
Based on interval cancer (IC) proportional incidence, biennal
screening sensitivity has been estimated to be as low as 75% (Paci
et al, 1990; Zappa et al, 2002). Thus, efforts should be made to
reduce IC frequency, and determining the causes of screening
faults is a baseline condition for further action.
At retrospective review (Egan and Mosteller, 1977; Ciatto et al,
1995a,b), most ICs are classified as ‘occult’ or ‘true interval’, a
relevant proportion as ‘minimal sign’ and a minority as ‘screening
error’. The corresponding frequencies determined for the Florence
District Programme were 61.9, 26.1 and 11.9%, respectively (Ciatto
et al, 1995a,b). Breast radiological density may have a masking
effect on small cancer lesions; it is likely to be a determinant of
false-negative mammography (Peeters et al, 1989), and might be
associated with IC, particularly in cases reviewed as ‘occult’. Other
variables, such as age (Wald et al, 1993), use of single or double
view (Bryan et al, 1995) and use of single or double reading (Ciatto
et al, 1995a,b) have been shown to be associated with
mammography sensitivity and might also be associated to IC.
In Florence District, mammographic screening has been on-
going at the Centro per lo Studio e la Prevenzione Oncologica
(CSPO) since 1970, being extended to Florence City in 1990.
Screening efficacy has been demonstrated by means of a case–
control study (Palli et al, 1986), and the proportional IC rate in
women aged 50–69 years has been reported to be 18% (95% CI
10–24) and 42% (95% CI 29–59) in the first or second year of the
interval, respectively: the sensitivity of biennal screening, esti-
mated on the basis of proportional IC incidence, was 75% (Paci
et al, 1990).
In the present study, a consecutive series of IC was compared to
screen-detected cancers (SDC), and the association of breast
density and other variables to IC was determined by univariate and
multivariate analysis. Parameters significantly and independently
associated to IC were identified, and the related implications on
screening modalities were discussed.
MATERIAL AND METHODS
The clinical records of all women attending the Florence City
screening programme from 1996 to 1999 were considered for the
study, and three groups of subjects were selected:
(a) all invasive ICs, diagnosed within 2 years after a negative
screening mammogram, were identified by linkage with CSPO
clinical archives (CSPO is the main breast clinic in the District,
diagnosing over 80% of all incident breast cancers in the area)
and with the Tuscany Cancer Registry, covering the whole
district area since 1985.
(b) all invasive SDC detected in the study period, as recorded in
the screening programme database
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l(c) a random sample of healthy subjects, with a negative screening
mammogram reported in the study period and at further
biennal screening, matched by age and screening year to IC
according to a 1:4 ratio
For all these subjects, the original screening mammograms were
blindly reviewed by one of us (SC) and the following variables were
recorded:
K number of mammographic views: according to the local
screening protocol, radiologists decide whether single- (medio-
lateral oblique) or double-view (mediolateral obliqueþcranio-
craniocaudal) mammography has to be performed at further
screening, single view being recommended for ‘low-density’
breasts. At further screening, computer-produced lists with
indication of the number of views to be taken are available to
the radiographer. First screening mammograms, or mammo-
grams for which the indication on the number of views is not
available, are always taken in two views:
K Wolfe’s parenchymal pattern, determined according to the
original classification (Wolfe, 1976) by one of us (SC) and
K breast density, calculated as the proportion of breast volume
occupied by fibro-glandular density. Cases were displayed on a
rotating viewer and classified directly by one of us (SC)
according to percentage breast density (0, 1–25, 26–74 and
474% density classes).
K IC type: IC had been previously classified by two expert CSPO
radiologists as (a) screening error, (b) minimal sign and (c)
radiologically occult, in accordance to EC guidelines (Perry et al,
2001).
The distribution of studied variables among SDC, IC and healthy
controls was first studied at univariate analysis: differences were
checked with the w
2 test, and statistical significance was set at
Po0.05. Multivariate analysis of the association of different
variables to IC was performed by means of multiple logistic
regression using the Stata 7.0 software.
RESULTS
The study considers (a) all (N¼346) SDC detected during 1996–
1999, (b) all (N¼90) subjects with a negative screening
mammogram in the same period and developing an IC in the
following 2 years and (c) a random sample of 360 subjects,
assumed as healthy controls (CO), with a negative mammography
during 1996–1999 and at further screening, after 2 years. Table 1
shows the distribution of studied cases by age: no difference was
evident as to age grouping (w
2¼0.7, P¼0.674), average or median
age when comparing cancers and negative controls, whereas a
minor, not statistically significant, difference was evident between
SDC and ICs (w
2¼5.3, P¼0.07).
Table 2 shows the association of studied variables to cancer and/
or IC. A significant difference in Wolfe pattern distribution (excess
of P2/DY patterns in cancers) was observed when comparing
cancers and negative controls (w
2¼14.3, P¼0.002), whereas no
significant difference was evident between SDC and ICs (w
2¼0.3,
P¼0.96). Whatever grouping of breast density classes was
considered (0/1–25/26–74/474%; 0–25/26–60/61–74/474%;
0–25/26–74/474%), a significantly different distribution (excess
density in cancers or in IC) was evident when comparing cancers
to negative controls (w
2¼46.6–48.2, Po0.01) or ICs to SDC
(w
2¼30.6–34.0, Po0.01). Overall, 27.8% of ICs were classified in
the 474% density class, as compared to 7% of SDC and 5% of
healthy controls. The distribution of cases by density quartiles
confirms the density pattern of the three groups: 75% of healthy
controls had a breast density o50% as compared to 60 and 75%
for SDC and ICs, respectively. A single oblique view was more
frequent, although with borderline significance, among healthy
controls as compared to cancers (w
2¼3.15, P¼0.08), whereas no
significant difference was evident when comparing SDC and ICs
(w
2¼0.02, P¼0.90). As far as the attended round (first or repeat)
was concerned, the proportion of ICs and SDC at first screening
was higher as compared to healthy controls (w
2¼33.0, P¼10
 6),
whereas no statistically significant difference was evident between
SDC and ICs (w
2¼1.4, P¼0.23).
The distribution of SDC and ICs according to the two studied
classifications (Wolfe’s pattern or percentage density) is shown in
Table 3. On a two-grade scale (N1-P1 vs P2-Dy patterns, and 0–25
vs 26–100% density), the association between Wolfe’s high-grade
(P2-Dy) and dense (425%) breasts was quite evident, with 96.6%
of cases falling in the N1-P1/0–25% or P2-Dy/26–100% sub-
groups.
Table 4 shows the results of multivariate analysis of the
association of different variables to IC. Wolfe’s parenchymal
Table 1 Distribution of studied cases by age
Age (years) CO (%) IC (%) SDC (%)
50–59 181 (50.3) 48 (53.3) 138 (39.9)
60–69 140 (38.9) 35 (38.9) 175 (50.6)
70+ 39 (10.8) 7 (7.8) 33 (9.5)
Total 360 (100) 90 (100) 346 (100)
Median age 59.2 59.3 62.4
SDC¼screen-detected cancer; IC¼interval cancers; CO¼healthy controls.
Table 2 Distribution of cases according to studied mammographic
features
CO (%) IC (%) SDC (%)
Wolfe pattern
N1 41 (11.4) 6 (7.5) 27 (8.1)
P1 174 (48.3) 28 (35.0) 98 (29.4)
P2 120 (33.3) 48 (48.7) 176 (52.9)
Dy 25 (7.0) 9 (8.8) 32 (9.6)
Density (I)
0% 36 (10.0) 2 (2.2) 26 (7.8)
1–25% 173 (48.1) 29 (32.2) 96 (28.8)
26–74% 133 (36.9) 34 (37.8) 187 (56.2)
474% 18 (5.0) 25 (27.8) 24 (7.2)
Density (II)
0–25% 209 (58.1) 31 (34.4) 122 (36.6)
26–60% 97 (26.9) 24 (26.7) 138 (41.4)
61–74% 36 (10.0) 10 (11.1) 49 (14.7)
474% 18 (5.0) 25 (27.8) 24 (7.2)
Density quartiles
25% 10 25 20
50% 25 50 40
75% 50 75 60
Mammographic views
1 240 (66.7) 51 (56.7) 190 (57.4)
2 120 (33.3) 39 (43.3) 141 (42.6)
Screening round
First 14 (3.9) 11 (12.2) 63 (18.2)
Repeat 346 (96.1) 79 (78.8) 283 (81.8)
SDC¼screen-detected cancer; IC¼interval cancers; CO¼healthy controls.
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with breast density, and the latter, fitting best at univariate
analysis, was used for logistic regression. Modification effects were
tested but not statistically significant. Older women had a lower
probability of developing IC (OR¼0.52 95% CI 0.3–09); breast
density showed a significant association to IC, particularly for the
475% density class (OR¼13.4, 95% CI 2.7–65.6). Attendance at
repeat rather than at first screening round was also associated to
IC, although not at a significant level (OR¼1.85, 95% CI 0.8–4.2),
whereas no significant association was evident for the number of
mammographic views used.
Table 5 shows the distribution of IC by density class and by the
type of screening error. The two variables were significantly
associated (w
2¼18.09, P¼0.03) as most IC classified as occult
occurred in dense breasts, whereas most screening errors occurred
in low-density breasts. No association to density was observed
among cases classified as minimal signs.
DISCUSSION
This study was aimed at identifying specific mammographic
features associated to IC, thus allowing the selection of subgroups
for alternative, more aggressive screening regimens (e. g. increased
screening frequency, routine ultrasonography).
Age was significantly associated to IC, a finding already reported
in screening studies (Paci et al, 1990; Wald et al, 1993). Differences
in breast density are the most likely explanation for the age-related
sensitivity of mammography, but the association observed in the
present study persisted after adjustment for breast density.
Nevertheless, the magnitude of such an association was too small
to justify a special screening regimen in younger women within
subjects eligible for screening (age 50–69 years).
Wolfe’s parenchymal pattern was associated to breast cancer,
confirming several previous reports on this subject (Wolfe, 1976).
Wolfe’s pattern classification has been questioned for its inter- and
intraobserver inconsistency. An analysis of intraobserver varia-
bility performed within this study on a subset of 300 cases on a
two-grade scale (N1/P1 vs P2/Dy patterns) gave an absolute
concordance rate of 85%. Wolfe’s Pattern distribution for SDC and
healthy controls in this study (P2-Dy; SDC¼62.5, CO (age 50–64
years)¼44.5%) was comparable to that observed (P2-Dy:
SD¼67%, CO¼59%) in a case–control study performed at the
Cambridge Screening Programme (Sala et al, 1998), with minor
differences possibly accounted for by differences in hormone
replacement therapy (HRT) use, or other factors associated with
dense parenchyma (e.g. diet). However, Wolfe pattern was not
significantly associated to the risk of IC, and thus was of no value
in selecting high-risk subjects to special screening regimens.
Proportional breast density attribution is also subjective, and
exposed to inter- and intraobserver variability. An analysis of
intraobserver variability performed within this study on a subset of
300 cases on a two-grade scale (0–25 vs 425% density) gave an
absolute concordance rate of 92%. To avoid such variability of eye
judgement, breast density might be quantitatively determined by a
computer on digitised films, but that would imply technology,
which is not currently available everywhere. Proportional breast
density is a purely quantitative parameter, directly associated to
the probability of a ‘masking effect’ (Egan and Mosteller, 1977),
whereas Wolfe’s classification is also based on morphological
criteria predictive of dysplasia (Ciatto and Zappa, 1993). The two
classifications are different, and this justifies our findings at
univariate analysis, which revealed a significant association to IC
risk only for proportional density and not for Wolfe’s pattern.
Hormone replacement therapy use has been reported to increase
breast density (Berkowitz and Gatewood, 1990) and potentially
affect screening efficacy (Ma et al, 1992). Hormone replacement
therapy was not recorded in the present study, but a previous
study in the adjacent district of Siena reported a 27.7% HRT use in
postmenopausal screening attenders (age 50–59 years), and
confirmed an increased probability of dense breast in HRT users
(density 425%¼þ17%, density 450%¼þ7%) as compared to
nonusers (Ciatto et al, 2001).
The number of mammographic views used has been reported to
affect mammography sensitivity, suggesting a higher frequency of
IC after a single-view as compared to two-view mammography
screening (Bryan et al, 1995). This was not evident in the present
study. The fact that the single view in our study was limited to
repeat screening and to selected subjects with nondense breast
might at least partially explain our findings.
In conclusion, the present study suggests a strong association of
breast density to screening sensitivity that is reduced in dense
Table 3 Distribution of cancer cases (screen detected and interval)
according to Wolfe’s and proportional density classification
Proportional density
Wolfe pattern 0 1–25% 26–74% 474% Total
N1 28 5 0 0 33 (7.8%)
P1 0 116 10 0 126 (29.8%)
P2 0 4 187 33 224 (53.0%)
DY 0 0 24 16 40 (9.4%)
Total 28 (6.6%) 125 (29.6%) 222 (52.5%) 49 (11.6%) 423 (100%)
Table 4 Results of multivariate analysis of the association of different
variables to detection as interval cancer
Variable Odds ratio Confidence limits P-value
Age (years)
50–59 1
a
60–69 0.52 0.30–0.90 0.02
Density
0% 1
a
1–25% 4.29 0.95–19.4 0.06
25–74% 2.28 0.51–10.2 0.28
474% 13.38 2.73–65.6 o.001
Mammographic views
11
a
2 0.76 0.41–1.44 0.41
Screening round
First 1
a
Repeat 1.85 0.81–4.2 0.14
aReference category.
Table 5 Classification of interval cancers according to proportional
breast density and error type
Proportional density
Error type 0 1–25% 25%–74% 474% Total
Screening error 1 11 6 1 19 (21.4%)
Minimal signs 1 8 14 8 31 (34.8%)
Occult 0
a 10 14 15 39 (43.8%)
aOne case not available for film review.
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lbreasts, a finding also reported in other studies (Ciatto and Zappa,
1993; Sala et al, 1998). High breast density (474%) was reported
in 28% of ICs as compared to 7.2% of SDC or 5% of healthy
controls. At multivariate analysis, the risk of IC (adjusted for
others covariates) associated to 474% density was significantly
higher (odd ratio¼5.1:1, 95% CI 2.6–10.0) as compared to
subjects with lower density values. Straightforward calculations
based on IC breast density would suggest that up to 22% of IC
might be prevented if adopting a special screening regimen in
subjects with 474% density would achieve the same sensitivity as
in the general population. These findings suggest the opportunity
to investigate alternative screening regimens (e.g. reduced
rescreening interval, routine use of ultrasound) to maximise
sensitivity in these subjects.
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